Aurobindo Pharma Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Aurobindo Pharma Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
AUROB.PHARMA

Click to see a quick summary and important updates about this stock!Dismiss

Aurobindo Pharma Ltd.

BSE: 524804, NSE: AUROPHARMA

  • Market Capitalisation info

    ₹26,599 Cr

  • 12 Month Earnings info

    ₹2,111 Cr

  • Price to Earnings info

    12.61

₹454.00

As on 09-Dec-2022 IST

up-down-arrow ₹-4.85 • -1.06%

  • Prev Close info

    ₹458.85

  • Day's Openinfo

    ₹460.00

  • Today's Highinfo

    ₹461.70

  • Today's Lowinfo

    ₹450.10

  • Today's Volumeinfo

    10,12,624

Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aurobindo Pharma
-38.18 -18.54 -16.25 -35.32 0.62 -7.56 16.74
S&P BSE Healthcare
-10.79 -2.67 1.25 -6.69 20.54 10.76 11.36
S&P BSE Mid Cap
4.51 1.05 0.77 2.29 21.17 8.89 13.95
As on 09-Dec-2022
2021
2020
2019
2018
2017
2016
2015
Aurobindo Pharma
-20.85 101.11 -37.69 7.16 2.79 -24.06 55.43
S&P BSE Mid Cap
39.18 19.87 -3.05 -13.31 48.13 7.97 7.43
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

View Details arrow

Peer Comparison

search
search
search
search
    Comparison Details arrow

    Valuation Chart

        Financials

        View Details arrow

        Shareholding Pattern

        View Details arrow

        News & Analysis

        img-stories

        Two attractive blue chip stocks in the mid cap space

        By Jugal Harpalani

        img-stories

        Multibaggers of the decade

        By Yash Rohra

        img-stories

        Large caps at a bargain

        By Jugal Harpalani

        img-stories

        Big shifts

        By Research Desk

        img-stories

        Picking cold stocks and converting them to cool ones

        img-stories

        Fall of Pharma

        By Mohammed Ekramul Haque

        All News arrow

        Other Details

        Incorporated

        1986

        Chairman

        K Ragunathan

        Managing Director

        K Nithyananda Reddy

        Group

        Aurobindo

        Headquarters

        Hyderabad, Telangana

        Website

        www.aurobindo.com
        More Details arrow
        Edit edit

        Key Facts

        • Market cap info

          ₹26,598.68 Cr

        • Revenue (TTM) info

          ₹23,786.88 Cr

        • Earnings (TTM) info

          ₹2,111.18 Cr

        • Cash info

          ₹6,471.64 Cr

        • Total Debt info

          ₹2,372.77 Cr

        • Promoters' ownership info

          51.83%

        • Liquidity info

          High

        • 52 Week range info

          ₹450.10 - 742.00

        • Face value info

          ₹1.00

        • Shares outstanding info

          58,59,38,609

        • 10 Years Aggregate:

          CFO: ₹23,188.60 Cr

          EBITDA: ₹34,486.56 Cr

          Net Profit: ₹23,058.01 Cr

        About The Company

        • Business

          Manufacture of allopathic pharmaceutical preparations

        • Incorporated

          1986

        • Chairman

          K Ragunathan

        • Managing Director

          K Nithyananda Reddy

        • Group

          Aurobindo

        • Listing info

          BSE: 524804, NSE: AUROPHARMA

        • Country

          India

        • Headquarters info

          Hyderabad, Telangana

        • Website info

          www.aurobindo.com

        Add Portfolio plue-icon Add to watchlist plue-icon Share Download Stock Report
        Portfolioplue-icon Watchlistplue-icon share-icon Download Stock Report
        Portfolioplue-icon Watchlistplue-icon share-icon